Profile
Edgar D.
Charles is Chief Medical Officer at Climb Bio, Inc. since 2025.
Dr. Charles was Vice President at Bristol Myers Squibb Co. from 2015 to 2025.
Dr. Charles completed undergraduate studies at The University of Chicago, graduate studies at The Rockefeller University, and earned a doctorate from The University of Alabama School of Medicine.
Edgar Charles active positions
| Companies | Position | Start |
|---|---|---|
| CLIMB BIO, INC. | Chief Tech/Sci/R&D Officer | 2025-06-17 |
Former positions of Edgar Charles
| Companies | Position | End |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 2024-12-31 |
Training of Edgar Charles
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
The University of Chicago
The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Rockefeller University
The Rockefeller University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Alabama School of Medicine
The University of Alabama School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eliem Therapeutics, Inc.
Eliem Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders | Health Technology |
- Stock Market
- Insiders
- Edgar Charles
















